Waller EK - Search Results

1

The yin and yang of adaptive immunity in allogeneic hematopoietic cell transplantation: donor antigen-presenting cells can either augment or inhibit donor T cell alloreactivity.

Li JM, Waller EK. Li JM, et al. Among authors: waller ek. Adv Exp Med Biol. 2007;590:69-87. doi: 10.1007/978-0-387-34814-8_5. Adv Exp Med Biol. 2007. PMID: 17191378 No abstract available.

2

Clinical use of irradiated donor lymphocytes in bone marrow transplantation.

Ship AM, Waller EK. Ship AM, et al. Among authors: waller ek. Cancer Treat Res. 1999;101:267-82. doi: 10.1007/978-1-4615-4987-1_12. Cancer Treat Res. 1999. PMID: 10800653 Review. No abstract available.

3

New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.

Waller EK, Boyer M. Waller EK, et al. Bone Marrow Transplant. 2000 May;25 Suppl 2:S20-4. doi: 10.1038/sj.bmt.1702347. Bone Marrow Transplant. 2000. PMID: 10933181 Clinical Trial.

4

Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation.

Waller EK, Rosenthal H, Jones TW, Peel J, Lonial S, Langston A, Redei I, Jurickova I, Boyer MW. Waller EK, et al. Blood. 2001 May 15;97(10):2948-56. doi: 10.1182/blood.v97.10.2948. Blood. 2001. PMID: 11342416 Free article.

5

Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.

Giver CR, Montes RO, Mittelstaedt S, Li JM, Jaye DL, Lonial S, Boyer MW, Waller EK. Giver CR, et al. Among authors: waller ek. Biol Blood Marrow Transplant. 2003 Oct;9(10):616-32. doi: 10.1016/s1083-8791(03)00229-5. Biol Blood Marrow Transplant. 2003. PMID: 14569558 Free article.

6

Reconstructing immunity after allogeneic transplantation.

Giver CR, Li JM, Hossain MS, Lonial S, Waller EK. Giver CR, et al. Among authors: waller ek. Immunol Res. 2004;29(1-3):269-82. doi: 10.1385/IR:29:1-3:269. Immunol Res. 2004. PMID: 15181288 Review.

7

Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.

Li JM, Waller EK. Li JM, et al. Among authors: waller ek. Biol Blood Marrow Transplant. 2004 Aug;10(8):540-51. doi: 10.1016/j.bbmt.2004.05.007. Biol Blood Marrow Transplant. 2004. PMID: 15282532 Free article.

8

Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.

Waller EK, Giver CR, Rosenthal H, Somani J, Langston AA, Lonial S, Roback JD, Li JM, Hossain MS, Redei I. Waller EK, et al. Blood Cells Mol Dis. 2004 Nov-Dec;33(3):233-7. doi: 10.1016/j.bcmd.2004.08.009. Blood Cells Mol Dis. 2004. PMID: 15528137 Clinical Trial.

9

Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.

Hossain MS, Roback JD, Lezhava L, Hillyer CD, Waller EK. Hossain MS, et al. Among authors: waller ek. Biol Blood Marrow Transplant. 2005 Mar;11(3):169-80. doi: 10.1016/j.bbmt.2004.12.332. Biol Blood Marrow Transplant. 2005. PMID: 15744235 Free article.

10

Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMT.

Li JM, Giver CR, Waller EK. Li JM, et al. Among authors: waller ek. Exp Hematol. 2006 Jul;34(7):895-904. doi: 10.1016/j.exphem.2006.03.008. Exp Hematol. 2006. PMID: 16797417 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters